Mass Spectrometry vs Amino Acid Analysis: What Peptide Tests Show

Mass spectrometry confirmation and amino acid analysis answer different questions about a peptide. Intact-mass MS checks whether the observed molecular mass fits the proposed molecule; tandem MS can add sequence evidence. Amino acid analysis (AAA) measures constituent amino acids and can support a peptide-content or concentration assignment when the sample and method are suitable.

They are not competing instrument labels. NIST’s quantitative AAA method uses isotope-dilution LC–MS/MS. The useful distinction is what is measured and what happens to the sample before measurement.

Sources checked: 23 October 2026. This is a guide to interpreting analytical evidence, not a laboratory protocol or a certification of any product.

Mass spectrometry vs amino acid analysis: the comparison

The distinction between qualitative MS evidence and quantitative AAA is explained in Bunk and Lowenthal’s NIST methods chapter. Quantitative targeted-MS evidence also needs an appropriate purpose and validation, as the Carr et al. assay-development recommendations explain. General expectations for selectivity, accuracy and precision are set out in ICH Q2(R2).

Why composition does not establish sequence

Consider two illustrative chains: alanine–glycine–serine and glycine–alanine–serine. They contain the same amino acids in the same proportions but have a different order. A composition result cannot tell those arrangements apart. Their unmodified intact masses also match; a more discriminating structural method is needed to resolve the identity question.

This is a conceptual example, not an experimental result. It explains why a claim of “confirmed amino acids” is narrower than a claim of sequence confirmation. NIST identifies accurate mass, peptide mapping and tandem-MS sequencing as more informative for qualitative characterisation than AAA alone.

What amino acid analysis can establish about quantity

After a peptide is broken into its constituent amino acids, measuring selected residues can support an estimate of peptide amount based on the known composition. Burkitt and colleagues’ primary study demonstrates the connection between amino-acid standards, peptide value assignment and traceable protein quantification. The assignment depends on successful hydrolysis, appropriate amino-acid recovery and a justified relationship between the measured residues and the peptide.

The full NIST methods chapter specifically warns that incomplete hydrolysis or amino-acid degradation can reduce accuracy. It calls for hydrolysis conditions to be validated for the particular protein or peptide. A numerical AAA result is therefore not automatically a reliable content value for every molecule.

The CPTAC-associated recommendations on peptide standards also discuss the stability and hydrolysis behaviour of different amino acids. A report should identify which residues support the assignment, rather than imply that every amino acid behaves identically.

Can amino acid analysis use mass spectrometry?

Yes. In the NIST method, LC–MS/MS measures amino acids using isotope dilution. The detector is a mass spectrometer, but the analytical target is the released amino acids. By contrast, an intact-peptide identity experiment examines the peptide itself. “MS” can therefore appear in both workflows while the scientific question changes.

Ask what the report actually identifies or quantifies. A method name without its analyte, units and purpose is not enough to interpret the result.

When is each kind of evidence useful?

This table is an editorial synthesis of the cited measurement principles, not a universal testing specification. The MS vs HPLC explainer covers separation and identity in more detail; the chromatogram guide explains peak-area interpretation.

Why there is no universal “best” method

A multi-laboratory study of oxytocin compared HPLC assay, quantitative NMR and AAA for content assignment. HPLC assay using the same peptide bulk material as the standard had the lowest inter-laboratory variability in that study. The authors also identified a limitation: that variability calculation excluded uncertainty in the standard’s purity assignment.

The published oxytocin comparison is useful because it separates reproducibility from the uncertainty attached to a reference value. Its result should not be generalised into a claim that one instrument or assay always outperforms every alternative for every peptide.

Five questions to ask of a report

1. What is the claim? Identity, sequence, composition, impurity level and content are separate claims.
2. What is the reported quantity? Look for the analyte, units and basis of calculation, rather than an unexplained percentage.
3. What makes the method suitable? The validation should address the measurement’s purpose and relevant interference.
4. What is the reference? A concentration assignment inherits uncertainty from its calibration and reference material.
5. Which sample was measured? The conclusion applies to the documented sample; broader claims require evidence of their own.

Use the certificate-of-analysis checklist to connect these questions to a report. Neither an identity match nor an amino-acid quantity measurement establishes clinical safety or Australian product approval; those are separate evidence and regulatory questions.

Primary methods and standards sources

• Bunk and Lowenthal, 2019: isotope-dilution LC–MS/MS for quantitative amino acid analysis; full NIST-hosted chapter.
• Hoofnagle et al., 2016: recommendations for peptide standards used in MS-based assays — consensus methods paper and published hydrolysis/stability figure.
• Carr et al., 2014: targeted peptide measurements and fit-for-purpose MS assay development — consensus measurement framework.
• Burkitt et al., 2008: traceable quantification from amino acids to proteins — primary quantitative-method study.
• Li et al., 2019: multi-laboratory oxytocin quantification comparison — primary comparative study.
• ICH Q2(R2), FDA-hosted final guidance — analytical-procedure validation principles.